Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIA (N2)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06614231
What this trial is testing

Neoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lung Cancer

Who this might be right for
NSCLC, Stage IIIANSCLC (non-small Cell Lung Cancer)
Sun Yat-sen University 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05894889
What this trial is testing

Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC

Who this might be right for
Stage IIIB(N2) Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung Cancer+1 more
Peking University 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06644313
What this trial is testing

Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Potentially Resectable MET-altered Non-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 31
Testing effectiveness (Phase 2)Study completedNCT00006469
What this trial is testing

Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Medstar Health Research Institute 30
Large-scale testing (Phase 3)UnknownNCT01407822
What this trial is testing

Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials 72
Not applicableTemporarily Not AvailableNCT01297101
What this trial is testing

Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Chest Hospital
Testing effectiveness (Phase 2)Ended earlyNCT02276560
What this trial is testing

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Who this might be right for
Stage IIIA Non-Small Cell Lung Cancer
UNC Lineberger Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT02572843
What this trial is testing

Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC Non-small Cell Lung Cancer
Swiss Cancer Institute 68
Testing effectiveness (Phase 2)UnknownNCT01784549
What this trial is testing

Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease

Who this might be right for
Non Small Cell Lung Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 168
Large-scale testing (Phase 3)Looking for participantsNCT06431633
What this trial is testing

Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

Who this might be right for
Lung DiseasesCarcinoma, Non-Small-Cell LungResectable Lung Non-Small Cell Carcinoma
Fundación GECP 129
Testing effectiveness (Phase 2)Study completedNCT00198367
What this trial is testing

Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Hospices Civils de Lyon 120
Testing effectiveness (Phase 2)Ended earlyNCT00924209
What this trial is testing

A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer

Who this might be right for
NSCLCStage IIIA (N2)
National Cancer Institute (NCI) 7
Not applicableStudy completedNCT02966769
What this trial is testing

N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation

Who this might be right for
Non-small-Cell Lung CarcinomaSurgeryStage IIIA-N2+2 more
Grupo de Investigación Clínica en Oncología Radioterapia 294
Large-scale testing (Phase 3)UnknownNCT00273494
What this trial is testing

Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2

Who this might be right for
Non-Small Cell Lung Cancer
Rigshospitalet, Denmark 406
Not applicableLooking for participantsNCT04677205
What this trial is testing

Molecular Signature From Tumor to Lymph Nodes

Who this might be right for
Lung CancerStage IIIA-cN2Operated With Curative Intent+2 more
Assistance Publique - Hôpitaux de Paris 200